GNAI1 and ovarian carcinoma: There is growing evidence that GNAI1 plays a role in human platelet aggregation [38], signal transduction of rat liver trypsin receptor, paclitaxel resistance of human ovarian cancer cells [39], hypotonia and epilepsy [40].